“Craig brings extensive operational leadership experience in regulated medical device manufacturing,” said Michael Dale, Chief Executive Officer, and Director, Axogen. “His background in scaling ...
The stock option is subject to the terms and conditions of Xilio Therapeutics’ 2022 Inducement Stock Incentive Plan, as well as the terms and conditions of the stock option agreement covering the ...
CNW/ - Global X Investments Canada Inc. (" Global X " or the " Manager ") announced today that the forward expenses and hedging costs payable by certain exchange traded funds (the " ETFs ") that it ...
Franklin BSP Realty Trust, Inc. (NYSE: FBRT) (“FBRT” or the “Company”) today announced that it will release its fourth quarter 2024 results on Thursday, ...